2008
DOI: 10.1016/j.jaci.2008.06.025
|View full text |Cite
|
Sign up to set email alerts
|

New perspectives on mechanisms underlying chronic allergic inflammation and asthma in 2007

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
26
0

Year Published

2010
2010
2019
2019

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 26 publications
(26 citation statements)
references
References 64 publications
0
26
0
Order By: Relevance
“…Literature precedent and analysis with Genomatix MatInspector identified three AP-1 sites, 298/291 (AP-1 [1]), 2552/2545 (AP-1 [2]), 21671/21664 (AP-1 [3]), conforming to the 12-O-tetradecanoylphorbol-13-acetate response element (TRE) or AP-1 consensus sequence 59-TGA(C/G)TCA-39 within the 21723/26 MMP-9 promoter region (28,29) (Fig. 1A).…”
Section: Promoter Constructs and Transfection And Luciferase Assaysmentioning
confidence: 99%
See 4 more Smart Citations
“…Literature precedent and analysis with Genomatix MatInspector identified three AP-1 sites, 298/291 (AP-1 [1]), 2552/2545 (AP-1 [2]), 21671/21664 (AP-1 [3]), conforming to the 12-O-tetradecanoylphorbol-13-acetate response element (TRE) or AP-1 consensus sequence 59-TGA(C/G)TCA-39 within the 21723/26 MMP-9 promoter region (28,29) (Fig. 1A).…”
Section: Promoter Constructs and Transfection And Luciferase Assaysmentioning
confidence: 99%
“…1A). Point mutations within the two proximal AP-1 sites at 298/291 bp (mAP-1 [1]) and 2552/ 2545 bp (mAP-1 [2]) were introduced using site-directed mutagenesis within the 21017/26 bp MMP-9 promoter luciferase construct. Forward primer sequences were as follows, with mutated residues depicted as lowercase letters: mAP-1 [1] 59-CTGACCCCTGAGTtgGCACTTGCCT-39 and mAP-1 [2] 59-AGAGGAAGCTGAGTtgAAGAAGGCT-39 (30).…”
Section: Promoter Constructs and Transfection And Luciferase Assaysmentioning
confidence: 99%
See 3 more Smart Citations